Pacira BioSciences Reaffirms Commitment to Enhancing Value for All Shareholders
Provided By GlobeNewswire
Last update: Apr 17, 2025
-- $300 million aggregate share repurchase authorization--
-- Reinforces confidence in 5x30 plan –
-- Continued focus on margin expansion and operational efficiency --
Read more at globenewswire.comNASDAQ:PCRX (12/16/2025, 9:31:19 AM)
26.495
-0.18 (-0.69%)
Find more stocks in the Stock Screener
